Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Eris Lifesciences IPO and IRB InvIT Fund IPO.
Eris Lifesciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while IRB InvIT Fund IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Eris Lifesciences IPO | IRB InvIT Fund IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Axis Capital Limited Citigroup Global Markets India Private Limited Credit Suisse Securities (India) Private Limited |
Credit Suisse Securities (India) Private Limited ICICI Securities Limited Idfc Bank Limited Iifl Securities Ltd |
| Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
|
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Eris Lifesciences IPO is up to ₹1,741.16 Cr whereas the issue size of the IRB InvIT Fund IPO is up to ₹5,921.10 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of IRB InvIT Fund IPO is ₹102.00 per share.
| Eris Lifesciences IPO | IRB InvIT Fund IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹102 per share |
| Issue Price (Lower) | ₹600.00 per share | ₹100.00 per share |
| Issue Price (Upper) | ₹603.00 per share | ₹102.00 per share |
| Issue Price (Final) | ₹603.00 per share | ₹102.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹60.00 per share | |
| Market Lot Size | 24 shares | 10000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | up to ₹4,300.00 Cr | |
| OFS Issue Size | 2,88,75,000 shares | 3,47,61,770 shares |
| OFS Issue Size (Amount) | ||
| Issue Size Total | 2,88,75,000 shares | 58,05,00,000 shares |
| Issue Size Total (Amount) | up to ₹1,741.16 Cr | up to ₹5,921.10 Cr |
Eris Lifesciences IPO opens on Jun 16, 2017, while IRB InvIT Fund IPO opens on May 03, 2017. The closing date of Eris Lifesciences IPO and IRB InvIT Fund IPO is Jun 20, 2017, and May 05, 2017, respectively.
| Eris Lifesciences IPO | IRB InvIT Fund IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 16, 2017 | May 03, 2017 |
| Issue Close | Jun 20, 2017 | May 05, 2017 |
| Basis Of Allotment (Tentative) | Jun 23, 2017 | |
| Initiation of Refunds (Tentative) | Jun 27, 2017 | |
| Credit of Share (Tentative) | Jun 28, 2017 | |
| Listing date (Tentative) | Jun 29, 2017 | |
| Anchor Lockin End date 1 | Jul 23, 2017 | |
| Anchor Lockin End date 2 | Sep 21, 2017 |
Eris Lifesciences IPO P/E ratio is , as compared to IRB InvIT Fund IPO P/E ratio of .
| Eris Lifesciences IPO | IRB InvIT Fund IPO | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | |||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||
| ROE | |||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||
| RoNW | |||||||||||||||||||||||||||||||||
In the Eris Lifesciences IPO retail investors (RII) are offered 28,72,500 shares while in IRB InvIT Fund IPO retail investors are offered 28,72,500 shares. Qualified institutional buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and 13,69,07,797 shares in IRB InvIT Fund IPO.
| Eris Lifesciences IPO | IRB InvIT Fund IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 86,17,500 shares | 13,69,07,797 shares |
| NII | 43,08,750 shares | |
| RII | 28,72,500 shares | |
| Employee | 1,50,000 shares | |
| Others | ||
| Total | 1,59,48,750 shares | 25,09,90,397 shares |
Eris Lifesciences IPO subscribed 3.29x in total, whereas IRB InvIT Fund IPO subscribed 8.57x.
| Eris Lifesciences IPO | IRB InvIT Fund IPO | |
|---|---|---|
| QIB (times) | 4.68x | 10.81x |
| NII (times) | 0.45x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.51x | |
| Employee (times) | 0.86x | |
| Other (times) | 5.89x | |
| Total (times) | 3.29x | 8.57x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
